Pharmacokinetic interactions between alcohol and other drugs

Clinical Pharmacokinetics

Volumn 33, Issue 2, 1997, Pages 79-90

  Fraser, Alan G ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; BENZODIAZEPINE DERIVATIVE; CYTOCHROME P450; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER METABOLISM; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW; STOMACH EMPTYING;

EID: 0030747937     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199733020-00001     Document Type: Review

References (152)

1. Lieher CS. Mechanisms of ethanol-drug-nutrition interactions. J Toxicol Clin Toxicol 1994; 32: 6311-81
2. Lieber CS. Susceptibility in alcohol-related liver injury. Alcohol Alcohol 1994:Suppl, 2: 315-26
3. Holford NHG. Clinical pharmacokinetics of ethanol. Clin Phurmacokinel 1987; 13: 273-92
4. Castuneda R, Sussman N, Westreich L, et al. A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders. J Clin Psych 1996; 57: 207-12
5. Ghodsc H. Combined use of drugs and alcohol. Curr Opin Psychiatry 1994; 7: 249-51
6. Adams WL. Interactions between alcohol and other drugs. Int J Addict 1995; 30: 1903-23
7. Smit JWA, Wijnne HJA, Schobben F, et al. Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastalin. Am J Curdiol 1995; 76: 89-96
8. Morgan DJ. McLeun AJ. Clinical pharmacokinetic and pharma- codynamic considerations in patients with liver disease. Clin Pharmaeokinel 1995; 29: 370-91
9. Thompson PJ. Social nocturnal alcohol consumption and pharmacokinetics of theophylline. Chest 1992; 101: 156-9
10. 2-receptor antagonists on the pharmacokinetics of alcohol consumed after food at lunchtime. Br J Clin Pharmacol 1994; 37: 371-4
11. Gupta AM, Baraona E, Lieber CS. Significant increase of blood alcohol by cimetidinc after repetitive drinking of small alcohol doses. Alcohol Clin Exp Res 1995; 19: 1083-7
12. Jones AW, Jonsson KA, Between subject und within-subject vnriutions in pharmacokineties of ethanol, Br J Clin Pharmacol 1994; 37 : 427-31
13. Fraser AG, Rosalki SB, Gamble GG, et al. Inter-individual and intra-individual variability of ethanol concentrution-time profiles: comparison of ethannl ingestion before or after an evening meal. Br J Clin Pharmacol 1995; 40: 387-92
14. Friel PN, Baer JS, Logan BK, Variability of ethunol absorption and breath concentrations during a large-scale alcohol administration study, Alcohol Clin Exp Res 1995; 19: 1055-60.
15. Riley SA, Sutcliffe K Kim M, et al. The influence of gastrointeslinul trunsit on drug absorption in healthy volunteers. Br J Clin Pharmacol 1992; 34: 32-9
16. Brophy CM, Moore JG. Christian PE, et al, Variability of gastric emptying measurements in man employing standardized radiolabelled meals. Dig Dis Sci 1986; 31: 799-806
17. Jones AW, Jonsson KA. food-induced lowering of blood-ethanol profiles und increased rale of metabolism immediately after a meal. J Forsensic Sci 1994; 39: 1084-93
18. Rogers J, Smith J, Starmer FA, et al. Differing effects of carbohydrate, fat and prolein on the rate of ethanol metabolism. Alcohol Alcohol 1987; 22: 345-53
19. Pikaar NA. Wedel M, Hermus RJJ. Influence of several factors on blood alcohol concentrations after drinking alcohol. Alcohol Alcohol 1988; 23: 289-97
20. Pfeiffer A, Hogl B, Kuess H. Effect of ethanol ingestion and commonly ingested alcoholic beverages on gastric emptying and gastro-intestinal transit. Clin Investig 1992; 70: 487-91
21. Wegener M, Schaffstein J, Digler U, et al. Gastrointestinal transit of solid-liquid meal in chronic alcoholics. Dig Dis Sci 1991; 36: 917-23
22. Kitson KE. Ethanol and acetaldehyde metabolism: past, present, and future. Rthanol Clin Hxp Res 1996; 20 Suppl. 8: 82A-92A
23. Wynne HA, Wood P, Herd B, et al. The association of age with the activity of alcohol dehygrogenuse in human liver. Age Aging 1992; 21: 417-20
24. Asai H, Imaoka S, Kuroki T, et al. Microsomal ethanol oxidising system activity by human hepatic cytochrome P450's. J Pharmacol Exp Ther 1996; 277: 1004-9
25. Song BJ. Ethunol-inducible cytochrome P450 (CYP2EI): biochemistry, molecular biology und clinical relevance: 1996 update. Alcohol Clin Exp Res 1996; 20 (8 Suppl.): 138A-46A
26. Lane EA, Guthrie S, Linnoila M. Effect of ethanol on drug and metabolite pharmacokinetics, Clin Pharmacokinet 1985; 10: 228-47
27. Sternehring B, Liden A, Andersson K, et al. Curbumazepine kinetics and adverse effects during und after ethanol exposure in alcoholics and in healthy volunteers. Eur J Clin Pharmacol 1992; 43: 393-7
28. Desmond PV, Patwardhan RV, Schenker S, et al. Short-term ethanol administration impairs the elimination of chlordiazcpoxide in man. Eur J Clin Pharmucol 1980; 18: 275-8
29. Hoyumpa AM, Patwardhan R, Maples M, et al. Effect of shortterm ethanol adminstration on lorazepum clearance. Hepalology 1981; 1: 47-53
30. Tsutumi R, Leo MA, Kim C, et al. Interaction of ethanol with enflurane metabolism und loxicity: role of P45011E1. Alcohol Clin Exp Res 1990; 14: 174-9
31. Bonkovsky HL, Kane RE, Jones DP, et al. Acute hepatic and renal loxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency. Hepatology 1994; 19: 1141-8
32. Collins C, Starmer GA. A review of the hepatoxicity of paracetamol at therapeutic or near therapeutic dose levels, with particular reference to alcohol users. Drug Alcohol Rev 1995; 14: 63-79
33. Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995; 22: 767-73
34. Lieher CS, Garro A, Leo MA, et al. Alcohol and cancer. Hepatology 1986; 6: 1005-19
35. Horowitz M, Maddox A, Handing PE, et al. Relationships between gastric emptying of solid and caloric liquid meals and alcohol absorption. Am J Physiol 1987; 256: G291-8
36. Roine R, Heikkonen E, Salaspuro M. Cisapride enhances alcohol absorption and leads to high blood alcohol levels [abstract]. Gastroenterology 1992; 102: A507
37. Edelbroek MA, Horowitz M, Wishart JM, et al. Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects. J Nucl Med 1993; 34: 582-8
38. Hebbard GS, Sun WM, Bochner F, et al. Pharmacokinetic considerations in gastrointestinal motor disorders. Clin Pharmacokinet 1995; 28: 41-66
39. Caballeria J, Frezza M, Hernandez Munoz R, et al. Gastric origin of the first-pass metabolism of ethanol in humans: effect of gastrectomy. Gastroenterology 1989; 97: 1205-9
40. Levitt MD. Antagonist: the case against first-pass metabolism of ethanol in the stomach. J Lab Clin Med 1994; 123: 28-31
41. Gentry RT, Baruona E, Lieber CS. Agonist: gastric first pass metabolism of alcohol. J Lab Clin Med 1994; 123: 21-6
42. Ammon E, Schafer C, Hofmann U, et al. Disposition and firstpass metabolism of ethanol in humans: is it gastric or hepatic and does it depend on gender. Clin Pharmacol Ther 1996; 59: 503-13
43. Saint-Blanquet G, Fritisch P, Deranche R. Alcohol dehydrogenase activity of the gastric mucosa following administration of alcohol to the rat. Puthol Biol 1972; 20: 249
44. Lamboeuf Y, De Saint-Blanquent G, Deranche R. Mucosal alcohol dehydrogenase and aldehyde dehydrogenase mediated ethanol oxidation in the digestive tract of the rat. Biochem Pharmacol 1981; 30: 542-5
45. Yin S-J, Wang M-F, Liao C-S, et al. Identification of a human stomach alcohol dehydrogenase with distinctive kinetic properties. Biochem Int 1990; 22: 829-35
46. Pares X, Moreno A, Cederlund E, et al. Class IV mammalian alcohol dehydrogenase: structural data of the rat stomach enzyme reveal a new class well seperated from those already characterised. FEBS Lett 1990; 277: 115-8
47. Moreno A, Pares X. Purification and characterisation of a new alcohol dehydrogenase from human stomach. J Biol Chem 1991; 266: 1128-33
48. Barona E, Yokoyama A, Ishii H, et al. Lack of alcohol dehydrogenase isoenzymes in the stomach of Japanese subjects. Life Sci 1991; 49: 1929-34
49. Frezza M, di Padova C, Pozzato G, et al. High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990; 322: 95-9
50. Thomasson HR. Gender differences in alcohol metabolism. Physiological responses to ethanol. Recent Dev Alcohol 1995; 12: 163-79
51. Seitz HK, Simanowski UA, Waldherr R, et al. Human gastricalcohol dehygroenase activity: effect of age, sex and alcoholism. Out 1993; 34: 1433-7
52. Brown AS, Fiaturone JR, Wood P, et al. The effect of gastritis on human gastric alcohol dehydrogenase activity and ethanol metabolism. Aliment Pharmacol Ther 1995; 9: 57-61
53. Pedrosa MC, Russell RM, Saltzman JR, et al. Gastric emptying and first pass metabolism of ethanol in elderly subjects with and without atrophic gastritis. Scand J Gastroenterol 1996; 31: 671-7
54. Lim Jr RT, Gentry RT, Ito D, et al. First-pass metabolism of ethanol is predominantly gastric. Alcohol Clin Exp Res 1993; 17: 1337-44
55. Julkensen RJ, DiPadova C, Lieber CS. First pass metabolism of ethanol: a gastrointestinal harrier against systemic toxicity of ethanol. Life Sci 1985; 37: S67-73
56. Di Padova C, Worner TM, Julkunen RJ, et al. Effects of fasting and chronic alcohol consumption on the first-pass metabolism of ethanol. Gastroenterology 1987; 92: 1169-73
57. Levitt MD, Levitt DG. The critical role of the rate of ethanol absorption in the interpretation of studies purporting to demonstrate gastric metabolism of ethanol. J Pharmacol Exp Ther 1994; 269: 297-304
58. Byrne AJ. McNeil JJ, Harrison PM, et al. Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rates as a determinant of pre-systemic drug interactions. Br J Clin Pharmacol 1984; 17: 45S-50S
59. Smith T, DeMaster EG, Furne JK, et al. First-pass gastric mucosul metabolism of ethanol is negligible in the rat. J Clin Invest 1992; 89: 1801-6
60. Smith T, DeMaster EG, Furne JK, et al. First-pass gastric mucosal metabolism of ethanol is negligible in the rat. J Clin Invest 1992; 89: 1801-6
61. Hernadez-Munoz R, Caballeria J, Baraona E, el al. Human gastric alcohol dehydrogenase: it's inhibition by H2-receptor antagonists, and it's effect on the bioavailability of ethanol. Alcohol Clin Exp Res 1990; 14: 946-50
62. Caballeria J, Baraona E, Deulofeu R, et al. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity. Dig Dis Sci 1991; 36: 1673-9
63. Mallat A, Roudot-Thoraval F, Bergmann J-F, et al. Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose. Br J Clin Pharmacol 1994; 37: 208-11
64. Raufman JP, Notar-Francesco V, Rasffaniello RD. Histamine2-receptor antagonists and serum ethanol levels. Ann Int Med 1993; 119: 953-5
65. 2-receptor antagonists and ethanol metabolism in man and in rats. Hepatology 1984; 4: 1231-4
66. Dobrilla G, de Pretis G, Piazzi L, et al. Is ethanol metabolism affected by oral administration of cimetidine and ranitidine at therapeutic doses? Hepatogaslroenterology 1984; 31: 35-7
67. 2-receptor antagonists on ethanol metabolism in Japanese volunteers. Br J Clin Pharmacol 1988; 26: 96-9
68. 2-receptor blockers on alcohol kinetics und psycophysical fitness. Bcilr Geschtl Med 1986; 44: 1-4
69. Jonsson KA, Jones AW, Bostrom H, et al. Lack of effect of onepraxole. and ranitidine on the pharmackinetics of ethanol in fasting mule volunteers. Eur J Clin Pharmacol 1990; 42: 209-12
70. Brown AS, James OFW, Cimetidine. ranitidine and omeprazole have no effect on peak hlood ethanol concentration, first pass metabolism or urea under the time/ethanol curve under real life conditions. Hepatology 1996; 23: 1-42
71. Toon S, Khan AZ, Holt BI, et al. Absence of effect of ranitidine on blood alcohol concentrations when taken morning, midday, or evening with or without food. Clin Pharmacol Ther 1994; 55: 385-91
72. Fraser AG. Prewell EJ, Hudson M, et al. Ranitidine has no effect on post-prandial ahsorption of alcohol (0,6g/kg) after an evening meal. Eur J Gastroenterol Hepatol 1992; 4: 43-8
73. Fraser AG, Hudson M, Sawyer AM, et al. Ranitidine, eimctidine, famotidine have no effect on post-prandial absorption of ethanol 0.8kg taken after an evening meal. Aliment Phurmacol Ther 1992; 6: 693-700
74. 1). Br J Clin Pharmacol 1996; 41: 129-33
75. Holtzman JL, Gehhard RL, Eckfield JH, et al. The effects of several weeks of ethanol consumption on ethanol kinetics in normal men and women. Clin Pharmacol Ther 1985; 38: 157-63
76. Webster LK, Jones DB, Smallwood RA. Influence of cimetidine and ranitidine on ethunol pharmacokinetics, Aust NZ J Med 1985; 15: 359-60
77. 2-receptor antagonists. Alcohol din Exper Res 1991; 15: 1084-5
78. Johnson KI, Fenzl E, Hein B. Influence of cimetidine on the elimination and effects of alcohol. Arzneimettel Forschung 1984; 34: 734-6
79. Feely J, Wood AJ. Effects of cimetidine on the elimination of ethanol, JAMA 1982; 247: 2819-21
80. Gupta SK, Ellinwood EH, Muir KT, et al. Ethanol pharmacodynamics at low blood concentrations. Am J Ther 1996; 3: 375-82
81. Cuballeria J, Barauna E, Rodamilans M, et al. Effects of cimetidine on gastric aleohul dchydrogenase activity and blood ethanol levels. Guslroenterology 1989; 96: 388-92
82. 2-receptor antagonists, JAMA 1992; 267; 83-6
83. Shurma R, Gentry T, Lim Jr RT. First-puss metabolism of alcohol: absence of diurnal variation and its inhibition by cimelidine after evening meal. Dig Dis Sci 1995; 40: 2091-7
84. Dauncey H, Chesher GB, Palmer RH. Cimetidine and ranitidine. Lack of effect on the pharmacokinetics of an acute ethanol dose. J Clin Gustroenterol 1993; 17: 189-94
85. Casini A, Pizzigallo AM, Mari F, et al. Prolonged bedtime treatment with H2-receptor antagonists (ranitidine and famotidine) does not affect blood alcohol levels after ethanol ingestion in male patients with duodenal ulcer. Am J Castroenterol 1994; 89: 745-9
86. Fraser AG, Prewett EJ, Hudson M, et al The effect of ranitidine. cimetidine or famotidine on low-dose post-prandial alcohol absorption. Aliment Phurmucul Ther 1991; 5: 263-72
87. Fraser AG, Sawyer AM, Hudson M, et al. The effect of ranitidine on post-breakfast alcohol absorption. Ain J Gastroenterol 1993; 88: 217-21
88. Kleine MW, Erll D. Comparative trial in volunteers in investigate passible ethanol-ranitidine interaction. Ann Pharmacother 1993; 27: 841-5
89. Brown AS, Kiaterone JR, Day CP, et al. Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism. Gut 1995; 37: 413-7
90. Fraser AG, Hudson M, Sawyerr AM, et al. The effect of ranitidine tin the post-prandial absorption of a low dose of alcohol, Aliment Pharmacol Ther 1992; 6: 267-71
91. Palmer RH, Frank WO, Nambi P, et al. Effects of various concomitant medications on gastric alcohol dehydrogenase und the first-pass metabolism of ethanol. Am J Gastroenterol 1991; 86: 1749-55
92. Dunhar JA, Penlilla A, Pikkarainen J. Drinking and driving: choosing the legal limits. BMJ 1987; 95: 1458-60
93. Palmer RH, Cimetidine and alcohol, Drug Investis 1994; 8: 63-5
94. Levitt MD. Lack of clinical significance of the interaction between H2-receptor antagonists and ethanol. Aliment Pharmacol Ther 1993; 7: 131-8
95. 2-antagonists and alcohol: do they interact? Drug Saf 1994; 10: 271-80
96. Pipkin GA, Mills JG, Woods JR, Does runitidine affect blood alcohol concentrations? Pharmacotherapy 1994; 14: 273-81
97. 2 antagonists and alcohol; none for the road? Drug Ther 1993; 23: 52-4
98. Houghton LA, Read NW. A comparative study of the effect of cimetidine and ranitidine on the rate of gastric emptying of liquid and solid lest meals in man. Aliment Pharmacol Ther 1987; 1: 401-8
99. Korrigan DD, Mangnall YF, Read NW, et al. Influence of acidpepsin secretion on gastric empying of solids in humans: studies with cimelidine. Gut 1491; 32: 1295-7
100. Amir I, Anwar N, Baraona E, et al. Ranitidine increases the bioavailability of imbibed alcohol by accelerating gastric emptying. Life Sci 1996; 58: 511-8
101. Burnham DB, Miller D, Karlstadl R, et al. Famotidine increases plasma alcohol concentration in healthy subjects. Aliment Pharmacol Ther 1994; 8: 55-61
102. 2-receptor antagonist famotidine on blood levels of alcohol and gastrin in healthy human subjects. Gut 1994: 35 Suppl. 4: 83
103. Puzzato G, Franzin F, Moretti M, et al. Effects of omeprazole on ethanol metabolism: an in viro and in vivo rat and human study. Pharmacol Res 1994; 29: 47-58
104. Rahal PS, Rahal SK, Katragudda R, et al. Effect of omeprazole on blood ethanol kinetics [abstract], Clin Res 1994; 42: 241A
105. Roine R, Hernandez-Munoz R, Buraona E, et al. Effect of omeprazole on gastric first-pass metabolism of ethanol. Dig Dis Sci 1992; 37: 891-6
106. Minocha A, Singh Rahal P, Brier ME, et al. Omepruzole therapy does not affect pharmacokinetics of orally administered ethanol in healthy male subjects. J Clin Gastroenterol 1995; 21: 107-9
107. Girre C, Coutelle C, David P, et al. Lack of effect of lunsopruzole on the pharmacokinetics ol'ethanol in male volunteers. Gastroenlerology 1994; 106 Suppl.: 504
108. Teyssen S, Singer MV, Heinz H, et al. Pantoprazole does not influence the pharmacokinetics of ethanol in healthy volunteers. Gastroenterology 1996; 110 Suppl.: 277
109. Johansson B. A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metuholites. Acta Psychiatr Scand Suppl 1992; 369: 15-26
110. Lassman HB, Huhhard JW, Chen BL, et al. Lack of interaction between cefpirome and alcohol. J Antimicroh Chemother 1992; 29 Suppl. A: 47-50
111. Vasiliou V, Malamas M, Marselos M. The mechanism of alcohol intolerance produced by various therapeutic drugs. Acta Pharmacol Toxicol 1986; 58: 303-10
112. Fett DL, Vukov LF. An unusual case of severe griseofulvin-alcohol interaction, Ann Emerg Med 1994; 24: 95-7
113. Lau AH, Lam NP, Piscitelli SC, et al. Clinical pharmacokinetics of metronidazole and other nicroimidazole anti-infectives. Clin Pharmacokinet 1992; 23: 328-64
114. Seitz C, Garcia P, Arancibia A, Influence of ethanol ingestion on tetracyclinc kinetics. Int J Clin Pharmacol Ther 1995; 33: 462-4
115. Larsen FG, Jakobsen P, Knudsen J, et al. Conversion of acitretin to etrelinatc in psoriatic patients is influenced by ethanol. J Invest Dermalol 1993; 100: 623-7
116. Wittes RC, Saginur R, Adverse reaction to mefloquine associated with ethanol ingestion. Can Med Assoc J 1995; 152: 515-7
117. Vuurman EFPM, Muntjewerff ND, Uiterwijk MMC, et al. Effects of metloquine along and with alcohol on psychomotor and driving performance, Eur J Clin Pharmacol 1996; 50: 475-82
118. Haffner HT, Wehner HD, Scheytt KD, et al. The elimination kinetics of methanol and the influence of ethanol. Int J Legal Med 1992; 105: 111-4
119. D'Arcy PF, Griffin JP. Interactions with drugs used in the treatment of depressive illness. Adv Drug Reactions Toxicol Rev 1992; 14: 211-31
120. Tiller JWG. Antidepressants. alcohol and psychomotor performance. Acta Psychiatr Scand 1990; Suppl. 360: 13-7
121. Hyatt MC, Bird MA, Amitrypyline augments and prolongs ethanol-induced euphoria. J Clin Pyschopharmacol 1987; 7: 277-8
122. Dorian P, Sellers EM, Reed KL. Amitriptyline and ethanol: pharmacokinctic and pharmacodynamic interaction. Eur J Clin Pharmacol 1983; 25: 325-31
123. Lemberg L, Rowe H, Berstrom RF, et al. The effect of fluoxetine on pysychomotor performance, physiologic response, and kinetics of ethanol. Clin Pharmacol Ther 1985; 37: 658-64
124. Kerr JS, Fairweather DB, Mahendran R, et al. The effects of paroxctinc. alone and in combination with ethanol on psychomotor performance and cognitive function in the elderly. Int Clin Psychopharmacol 1992; 7: 101-8
125. Van Harten J, Stevens LA, Raghochar M, et al. Fluvoxamine docs not interact with ethanol or potentiate alcohol-related impairment of cognitive function. Clin Pharmacol Ther 1992; 52: 427-35
126. Hoyovadillo C, Mandema JW, Danhof M. Pharmacodynamic interaction between midazolum and a low dose of ethanol in vivo. Life Sci 1995; 57: 325-33
127. Lichtor JL, Korttila K, Apfelbaum J, et al. Alcohol after midazolam sedation: does it really matter? Anesth Anulg 1990; 70 Suppl.: 237
128. Linnoila M, Stapleton JM, Moss H, et al. Effects of single doses of alprazolam and diazepam, alone und in combination with ethanol, on psychomotor und cognitive performance and on autonomie nervous system reactivity in healthy volunteers. Eur J Clin Pharmacol 1990; 39: 21-8
129. Sellers EM, Busto U. Benzodiazepines and ethanol: assessment of the effects and consequences of psychotropic drug interactions. J Clin Psychpharmacol 1982; 2: 249-62
130. Huyes SL, Publo C, Radomski T, et al. Ethanol and oral diazepam absorption. N Eng J Med 1977; 296: 186-9
131. Lichtor JL, Zacny JP, Coalson DW, et al. The interaction between ethanol and the residual effects of thiopental anaesthesia. Anaesthesiology 1993; 79: 28-35
132. Motherway C, Colreavy F, Denish N, et al. Induction dose of propofol: the effect of alcohol intake. Br J Anaesth 1995; 74 Suppl. 1:82
133. Fassoulaki A, Farinotti R, Servin F, et al. Chronic alcoholism increases the induction dose of propofol in humans. Anesth Analg 1993; 77: 553-6
134. Swift RM, Davidson D, Whelihan W, et al. Ondansetron alters human alcohol intoxication. Biol Psychiatry 1996; 40: 514-21
135. Mosce L, Huther KJ, Koch-Weser J, et al. Effects of terfenadine or diphenhydraminc alone, and in combination with diazepam or alcohol on pyschomotor performance and subjective feelings. Eur J Clin Pharmacol 1978; 14: 417-23
136. Patat A, Stubbs D, Dunmore C, et al. Lack of interaction between two antihistamines. mizolastine and celrizine. and ethanol in pyschomotor and driving performance in healthy subjects. Eur J Clin Pharmacol 1995; 48: 143-50
137. Richens A. Pharmacokinetic and pharmacodynamic drug interactions during treatment with vigabatrin. Acla Neurol Scand Suppl 1995; 162: 43-6
138. MacMahon S. Alcohol consumption and hypertension. Hypertension 1987; 9: 111-21
139. Schuckit MA. Alcohol and depression: a clinical perspective. Acla Psychiatr Scund Suppl 1994; 89 Suppl. 377: 28-32
140. Krentz AJ, Ferner RE, Bailey CJ. Comparative tolerability profiles of oral antidiabetic agents. Drug Saf 1994 ; 11: 223-41
141. Chan JCN, Cockram CS, Critchley JAJH. Drug-induced disorders of glucose metabolism: mechanisms and management. Drug Saf 1996: 15: 135-57
142. Ginsburg ES, Mello NK, Mendelson JH, et al. Effects of ethanol ingestion on estrogens in postmenopausal women. JAMA 1996; 276: 1747-51
143. Sellers EM. Frecker RC, Romach MK. Drug metabolism in the elderly: confounding of age. smoking and ethanol effects. Drug Metab Rev 1983; 14: 225-50
144. Berstein LR, Folkmun S, Lazarus RS. Characterisation of the use and misuse of medications by an elderly ambulatory population. Med Care 1989; 27: 654-63
145. Adams WL. Potential for adverse drug-alcohol interactions among retirement community residents. J Am Geriatr Soc 1995; 43: 1021-5
146. Forster LE, Follow R, Stoller EP. Alcohol use and potential risk for alcohol-related adverse drug reactions among community based elderly. J Comm Health 1993; 18: 225-39
147. Melandcr O, Lidauen A, Melandcr A, Pharmacokinetic interactions of alcohol und acelylsalicylic acid. Eur J Clin Pharmacol 1995; 48: 151-3
148. Sharma SC, Feely J. The influence of aspirin and paracetamol on blood concentrations of alcohol in young adults. Br J Clin Pharmacol 1996; 41: 467
149. Roine R, Gentry T, Hernandez-Munoz R, et al, Aspirin increases hlood alcohol concentrations in humans after ingestion of ethunol. JAMA 1990; 264; 24106-8
150. Deykin D, Junson P, McMahon L. Ethanol potentiation of aspirin-induced prolongation of the bleeding lime. N Eng J Med 1982; 306: 852-4
151. Henry D, Dohson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-intlammalory drugs. Gastroenterology 1993; 105: 1078-88
152. Johnson OR, Wen SF. Syndrome of flank pain and acute renal failure after binge drinking and non-steroidal antiinflammatory drug ingestion. J Am Soc Nephrol 1995; 5: 1647-52